Argenica Therapeutics Ltd (AU:AGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argenica Therapeutics Ltd has successfully passed all resolutions during their Annual General Meeting held on 14 August 2024, including the ratification of prior securities issues and the grant of options to Dianne Angus. The company has released the full details of the proxy votes and the percentages of votes for and against each resolution.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.